Published in

Taylor and Francis Group, Leukemia & Lymphoma, 10(61), p. 2536-2537, 2020

DOI: 10.1080/10428194.2020.1786559

Links

Tools

Export citation

Search in Google Scholar

Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

Journal article published in 2020 by Claudio Galvao de Castro Jr. ORCID, Lauro Jose Gregianin ORCID, Jan A. Burger ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO